Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-centre, randomised, placebo-controlled, double-blind, parallel-group
comparative trial to be conducted in nocturia patients. The trial is designed to characterize
the dose-response relationship of Minirin (desmopressin) Melt in order to establish correct
dose recommendations in the target patient population. In particular, the trial is designed
to link the duration of action to the clinical endpoint. Furthermore, the trial is designed
to describe the safety of four different dose levels of desmopressin.